View in EDS

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.

Saved in:
Bibliographic Details
Title: Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.
Authors: Rothenberg ML; University of Texas Health Science Center at San Antonio, USA. mace.rothenberg@mcmail.vanderbilt.edu, Sharma A, Weiss GR, Villalona-Calero MA, Eckardt JR, Aylesworth C, Kraynak MA, Rinaldi DA, Rodriguez GI, Burris HA 3rd, Eckhardt SG, Stephens CD, Forral K, Nicol SJ, Von Hoff DD
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1998 Jul; Vol. 9 (7), pp. 733-8.
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Print ISSN: 0923-7534 (Print) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 9739439
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rothenberg+ML%22">Rothenberg ML</searchLink>; University of Texas Health Science Center at San Antonio, USA. mace.rothenberg@mcmail.vanderbilt.edu<br /><searchLink fieldCode="AU" term="%22Sharma+A%22">Sharma A</searchLink><br /><searchLink fieldCode="AU" term="%22Weiss+GR%22">Weiss GR</searchLink><br /><searchLink fieldCode="AU" term="%22Villalona-Calero+MA%22">Villalona-Calero MA</searchLink><br /><searchLink fieldCode="AU" term="%22Eckardt+JR%22">Eckardt JR</searchLink><br /><searchLink fieldCode="AU" term="%22Aylesworth+C%22">Aylesworth C</searchLink><br /><searchLink fieldCode="AU" term="%22Kraynak+MA%22">Kraynak MA</searchLink><br /><searchLink fieldCode="AU" term="%22Rinaldi+DA%22">Rinaldi DA</searchLink><br /><searchLink fieldCode="AU" term="%22Rodriguez+GI%22">Rodriguez GI</searchLink><br /><searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink><br /><searchLink fieldCode="AU" term="%22Eckhardt+SG%22">Eckhardt SG</searchLink><br /><searchLink fieldCode="AU" term="%22Stephens+CD%22">Stephens CD</searchLink><br /><searchLink fieldCode="AU" term="%22Forral+K%22">Forral K</searchLink><br /><searchLink fieldCode="AU" term="%22Nicol+SJ%22">Nicol SJ</searchLink><br /><searchLink fieldCode="AU" term="%22Von+Hoff+DD%22">Von Hoff DD</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 1998 Jul; Vol. 9 (7), pp. 733-8.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0923-7534 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=9739439
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1023/a:1008286908930
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 733
    Titles:
      – TitleFull: Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rothenberg ML
      – PersonEntity:
          Name:
            NameFull: Sharma A
      – PersonEntity:
          Name:
            NameFull: Weiss GR
      – PersonEntity:
          Name:
            NameFull: Villalona-Calero MA
      – PersonEntity:
          Name:
            NameFull: Eckardt JR
      – PersonEntity:
          Name:
            NameFull: Aylesworth C
      – PersonEntity:
          Name:
            NameFull: Kraynak MA
      – PersonEntity:
          Name:
            NameFull: Rinaldi DA
      – PersonEntity:
          Name:
            NameFull: Rodriguez GI
      – PersonEntity:
          Name:
            NameFull: Burris HA 3rd
      – PersonEntity:
          Name:
            NameFull: Eckhardt SG
      – PersonEntity:
          Name:
            NameFull: Stephens CD
      – PersonEntity:
          Name:
            NameFull: Forral K
      – PersonEntity:
          Name:
            NameFull: Nicol SJ
      – PersonEntity:
          Name:
            NameFull: Von Hoff DD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 1998 Jul
              Type: published
              Y: 1998
          Identifiers:
            – Type: issn-print
              Value: 0923-7534
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1